钟奇祺;张海波;幸清凤;关玮琨;廖晓鹏;黎力之;郭冬生;
ZHONG Qiqi;ZHANG Haibo;XING Qingfeng;GUAN Weikun;LIAO Xiaopeng;LI Lizhi;GUO Dongsheng;College of Life Science and Resources and Environment, Engineering Technology Research Center of Jiangxi Universities and Colleges for Selenium Agriculture, Yichun Key Laboratory of Functional Agriculture and Ecological Environment, Yichun University;Office of Financial Affairs, Yichun University;School of Continuing Education, Yichun University;

• 1:宜春学院生命科学与资源环境学院江西省高等学校硒农业工程技术研究中心宜春市功能农业与生态环境重点实验室
• 2:宜春学院计划财务处
• 3:宜春学院继续教育学院

摘要(Abstract)：

动物肠道内栖息着大量微生物,肠道微生物及其代谢产物积极参与肠道免疫稳态的建立,对防控肠道疾病具有积极影响,在动物健康中发挥不可或缺的调节作用。本文对肠道微生物及其代谢产物对宿主肠道免疫的影响进行综述,旨在为调控肠道免疫、治疗动物疾病及保障机体健康提供思路和参考。
A large number of microorganisms inhabit the intestinal tract of animals, and their own and their metabolites actively participate in the establishment of intestinal immune homeostasis, which has a positive impact on the prevention and control of intestinal diseases and plays an indispensable regulatory role in animal health. This paper reviews the effects of intestinal microorganisms and their metabolites on host intestinal immunity, aiming to provide ideas and perspectives for regulating intestinal immunity, treating animal diseases and safeguarding body health.

关键词(KeyWords)： 肠道;微生物;代谢产物;肠黏膜免疫
Intestinal;Microorganism;Metabolites;Intestinal mucosal immunity

Abstract:

Keywords:

基金项目(Foundation): 国家地区科学基金项目（32060773）;; 江西省教育厅项目（GJJ190848）;; 江西省现代农业产业技术体系建设专项资金资助（JXARS-14）;; 宜春学院博士科研启动基金（3350100050）;宜春学院科研发展基金项目（kyfzl2020008）

作者(Authors): 钟奇祺;张海波;幸清凤;关玮琨;廖晓鹏;黎力之;郭冬生;
ZHONG Qiqi;ZHANG Haibo;XING Qingfeng;GUAN Weikun;LIAO Xiaopeng;LI Lizhi;GUO Dongsheng;College of Life Science and Resources and Environment, Engineering Technology Research Center of Jiangxi Universities and Colleges for Selenium Agriculture, Yichun Key Laboratory of Functional Agriculture and Ecological Environment, Yichun University;Office of Financial Affairs, Yichun University;School of Continuing Education, Yichun University;

DOI: 10.19556/j.0258-7033.20200324-04

参考文献(References)：

• [1]Zhao Q,Elson C O.Adaptive immune education by gut microbiota antigens[J].Immunology,2018,154(1):28-37.
• [2]Wang G,Huang S,Wang Y,et al.Bridging intestinal immunity and gut microbiota by metabolites[J].Cell Mol Life Sci,2019,76:3917-3937.
• [3]Masahata K,Umemoto E,Kayama H,et al.Generation of colonic IgA-secreting cells in the caecal patch[J].Nat Commun,2014,5(1):3704-3716.
• [4]Gurybenari M,Thaiss C A,Serafini N,et al.The spectrum and regulatory landscape of intestinal innate lymphoid cells are shaped by the microbiome[J].Cell,2016,166(5):1231-1246.
• [5]Ngo V L,Abo H,Maxim E,et al.A cytokine network involving IL-36γ,IL-23,and IL-22 promotes antimicrobial defense and recovery from intestinal barrier damage[J].P Natl Acad Sci USA,2018,115(22):5076-5085.
• [6]Hapil F Z,Wingender G.The interaction between invariant natural killer T cells and the mucosal microbiota[J].Immunology,2018,155(2):164-175.
• [7]Rothhammer V,Mascanfroni I D,Bunse L,et al.Type Iinterferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor[J].Nat Med,2016,22(6):586-600.
• [8]Su Y,Ren X,Li Y,et al.Differences of mice gut microbiota between SPF and clean environment[J].J Glycobiol,2018,7(134):2-5.
• [9]Gu S,Chen D,Zhang J,et al.Bacterial community mapping of the mouse gastrointestinal tract.[J].PLoS One,2013,8(10):74957-74965.
• [10]Schneider H,Pelaseyed T,Svensson F,et al.Study of mucin turnover in the small intestine by in vivo labeling.[J].Sci RepUk,2018,8(1):5760-5770.
• [11]Levy M,Thaiss C A,Elinav E.Metabolites:messengers between the microbiota and the immune system[J].Gene Dev,2016,30:1589-1597.
• [12]Lamichhane S,Sen P,Dickens A M,et al.Gut metabolome meets microbiome:a methodological perspective to understand the relationship between host and microbe[J].Methods,2018,149:3-12.
• [13]Altamura F,Maurice C F,Castagner B.Drugging the gut microbiota:toward rational modulation of bacterial composition in the gut[J].Curr Opin Chem Biol,2020,56:10-15.
• [14]Blandford L E,Johnston E L,Sanderson J D,et al.Promoter orientation of the immunomodulatory Bacteroides fragilis capsular polysaccharide A (PSA) is off in individuals with inflammatory bowel disease (IBD)[J].Gut Microbes,2019,10:1-9.
• [15]Sittipo P,Lee Y K,Choi K,et al.Toll-like receptor 2-mediated suppression of colorectal cancer pathogenesis by polysaccharide A from Bacteroides fragilis[J].Front Microbiol,2018,9:1588-1598.
• [16]Yang F,Yang L,Chang Z,et al.Regulation of virulence and motility by acetate in enteropathogenic Escherichia coli[J].Int JMed Microbiol,2018,308(7):840-847.
• [17]Ridlon J M,Harris S C,Bhowmik S,et al.Consequences of bile salt biotransformations by intestinal bacteria[J].Gut Microbes,2016,7(1):22-39.
• [18]Fiorucci S,Biagioli M,Zampella A,et al.Bile acids activated receptors regulate innate immunity[J].Front Immunol,2018,9:1853-1869.
• [19]Jason D,Christopher J,Spencer C,et al.Bile acid 7α-dehydroxylating gut bacteria secrete antibiotics that inhibit clostridium difficile:role of secondary bile acids[J].Cell Chemical Biology,2019,26(1):27-34.
• [20]Rooks M G,Garrett W S.Gut microbiota,metabolites and host immunity[J].Nat Rev Immunol,2016,16(6):341-352.
• [21]Quraishi M N,Shaheen W,Oo Y H,et al.Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease[J].Clin Exp Immunol,2020,199(1):24-38.
• [22]俞昊男,刘志华.肠道微生物与黏膜免疫研究的前沿进展[J].中国免疫学杂志,2019,35(16):1921-1930.
• [23]Reboldi A,Arnon T I,Rodda L B,et al.IgA production requires B cell interaction with subepithelial dendritic cells in Peyer’s patches[J].Science,2016,352(6287):4822-4821.
• [24]Cong Y,Li Y.Different flavors of IL-21 in regulation of intestinal IgA to commensals[J].Mucosal Immunol,2019,12(1):36-38.
• [25]Camposrodriguez R,Godinezvictoria M,Abarcarojano E,et al.Stress modulates intestinal secretory immunoglobulin A[J].Front Integr Neurosc,2013,86 (7):1-10.
• [26]Lemme-Dumit J M,Polti M A,Perdigon G,et al.Probiotic bacteria cell walls stimulate the activity of the intestinal epithelial cells and macrophage functionality[J].Benef Microbes,2018,9(1):153-164.
• [27]Chan J L,Wu S,Geis A L,et al.Non-toxigenic Bacteroides fragilis (NTBF) administration reduces bacteria-driven chronic colitis and tumor development independent of polysaccharide A[J].Mucosal Immunol,2019,12(1):164-177.
• [28]Zhou L,Zhang M,Wang Y,et al.Faecalibacterium prausnitzii produces butyrate to maintain Th17/Treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase1[J].Inflamm Bowel Dis,2018,24(9):1926-1940.
• [29]Lee J Y,Hall J A,Kroehling L,et al.Serum amyloid A proteins induce pathogenic Th17 cells and promote inflammatory disease[J].Cell,2019,180:1-13.
• [30]Kayama H,Takeda K.Mucosal regulatory system for balanced immunity in the gut[M].New York:Mucosal Vaccines Academic Press,2020:247-254.
• [31]Agalioti T,Villablanca E J,Huber S,et al.Th17 cell plasticity:the role of dendritic cells and molecular mechanisms[J].JAutoimmun,2018,87:50-60.
• [32]Campbell C,Dikiy S,Bhattarai S K,et al.Extrathymically generated regulatory T cells establish a niche for intestinal border-dwelling bacteria and affect physiologic metabolite balance[J].Immunity,2018,48(6):1245-1257.
• [33]Atarashi K,Tanoue T,Oshima K,et al.Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota[J].Nature,2013,500(7461):232-236.
• [34]Pandiyan P,Bhaskaran N,Schneider E,et al.Microbiome dependent regulation of Tregs and Th17 cells in mucosa[J].Front Immunol,2019,10:426-442.
• [35]Ladinsky M S,Araujo L P,Zhang X,et al.Endocytosis of commensal antigens by intestinal epithelial cells regulates mucosal T cell homeostasis[J].Science,2019,363(6431):1058-1057.
• [36]Mao K,Baptista A P,Tamoutounour S,et al.Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism[J].Nature,2018,554(7691):255-259.
• [37]Tasaki S,Cho T,Nagao J,et al.Th17 cells differentiated with mycelial membranes of Candida albicans prevent oral candidiasis[J].Fems Yeast Res,2018,18(3):1093-1123.
• [38]Atarashi K,Tanoue T,Ando M,et al.Th17 cell induction by adhesion of microbes to intestinal epithelial cells[J].Cell,2015,163(2):367-380.
• [39]Wang L,Beier U H,Akimova T,et al.Histone/protein deacetylase inhibitor therapy for enhancement of Foxp3+T-regulatory cell function posttransplantation[J].Am J Transplant,2018,18(7):1596-1603.
• [40]Postler T S,Ghosh S.Understanding the holobiont:how microbial metabolites affect human health and shape the immune system[J].Cell Metab,2017,26(1):110-130.
• [41]Wrzosek L,Miquel S,Noordine M L,et al.Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent[J].BMC Biol,2013,11(1):61-73.
• [42]Molinaro A,Wahlstr?m A,Marschall H U.Role of bile acids in metabolic control[J].Trends Endocrin Met,2018,29(1):31-41.
• [43]Duboc H,Rajca S,Rainteau D,et al.Connecting dysbiosis,bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases[J].Gut,2013,62(4):531-539.
• [44]Den Bossche L V,Hindryckx P,Devisscher L,et al.Ursodeoxycholic acid and its taurine-or glycine-conjugated species reduce colitogenic dysbiosis and equally suppress experimental colitis in mice[J].Appl Environ Microb,2017,83(7):2766-2782.
• [45]Guinan J,Villa P,Thangamani S,et al.Secondary bile acids inhibit Candida albicans growth and morphogenesis[J].Pathog Dis,2018,76(3):38-61.